论文部分内容阅读
本文对临床诊断为乙型慢性肝炎68例病人随机分为两组。治疗组用卡介苗免疫羊的肝脾等组织提取的免疫糖核酸治疗。对照组用一般保肝药物治疗。结果:GPT、TTT、ZTT、恢复正常例数的百分数,治疗组各为62.5%,55.5%,64.2%;对照组各为14.8%,19.0%,30.0%。两组差异显著(前者P<0.01,后两者P<0.05)。HBeAg及循环免疫复合物的阴转率,治疗组各为60.7%及67.7%;对照组各为22.2%及31.5%,两组差异非常显著(P<0.005)。
In this paper, 68 cases of clinical diagnosis of chronic hepatitis B were randomly divided into two groups. Treatment group with BCG immune sheep liver and spleen and other tissues extracted immune sugar nucleic acid therapy. Control group with general liver drug treatment. Results: The percentages of GPT, TTT, ZTT and normal cases were 62.5%, 55.5% and 64.2% respectively in the treatment group and 14.8%, 19.0% and 30.0% in the control group. There was significant difference between the two groups (former P <0.01, latter two P <0.05). The negative conversion rates of HBeAg and circulating immune complexes were 60.7% and 67.7% in the treatment group and 22.2% and 31.5% in the control group, respectively, with significant differences between the two groups (P <0.005).